secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2026-06-12T20:50:36+00:00
Accession:  0001493152-26-028489
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis stockholders elect all six director nominees, approve equity plan amendments at annual meeting
--------------------------------------------------------------------------------

- Six director nominees elected: Brian Carrico, Dr. Christopher R Brown, Bradley Mitch Watkins, Beth Keyser, Kristen Ferge, Dr. Gilad Aharon; each received 96-99% of votes.
- Ratification of Rosenberg Rich Baker Berman as independent auditor for FY 2026 approved (10,187,191 votes for, 0 against, 16,815 abstentions).
- Third amendment to Neuraxis 2022 Omnibus Securities and Incentive Plan (solely Section 5.1) approved with 6,730,816 votes for, 727,030 against.
- Neuraxis 2025 Employee Stock Purchase Plan approved as amended; Section 5(c) changed to 10% ownership limit from 5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/0001493152-26-028489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer